Verfahren zur Behandlung von Neugeborenen mit Igf-1-Komplex

Details

Veröffentlichungs-Nr.

EP4768080

Anmeldetag

4. Oktober 2023

Veröffentlichung

1. Juli 2026

Rechtsraum

EP

IPC

A61P25/00

Abstract

The present disclosure relates to treatment of subpopulation of neonates for reducing the risk of IVH and/or severe IVH, such as grade 3 or 4 IVH by administering a therapeutic amount of a composition comprising IGF-1 and an IGF binding protein (such as IGFBP-3), for example as a complex, at a dose of 200-500µg/Kg/day. In a further aspect there is provided stabilisation of vital functions when hyperosmolarity occurs and/or protection from circulatory collapse.

Anmelder

Firma

OAK HILL BIO LIMITED

Land

🇬🇧 Großbritannien